Vimarsana
Biggest News Aggregation in the World

Page 41 - Cap Limited News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cap Limited. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cap Limited Today - Breaking & Trending Today

Investegate |Chaarat Gold Hlgs Ld Announcements | Chaarat Gold Hlgs Ld: Fundraise and Planned Debt Reduction - Vimarsana News

Investegate |Chaarat Gold Hlgs Ld Announcements | Chaarat Gold Hlgs Ld: Fundraise and Planned Debt Reduction

  The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). Not for release, publication, or distribution to United States newswire services or for release, publication or dissemination in the United States and does not constitute an offer of the securities herein.   This press release does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States or any other jurisdiction. Any securities described...

Investegate |Wameja Limited Announcements | Wameja Limited: Scheme of Arrangement Update - Vimarsana News

Investegate |Wameja Limited Announcements | Wameja Limited: Scheme of Arrangement Update

  Wameja (LSE: WJA.L & ASX: WJA.AX), a joint venture partner with Mastercard in the HomeSend global payment hub, provides a further update regarding the Scheme of Arrangement ("Scheme") proposed under the Scheme Implementation Agreement ("SIA") with Burst Acquisition Co. Pty. Ltd, a company controlled by Mastercard ("Mastercard"), as announced on 10 September 2020 ("Announcement") .     In its announcement of 23 October 2020, Wameja advised that Seamless Distribution Systems AB ("Seamless"), the purchaser under the sale and purchase agree...

Investegate |Jupiter Green InvTst Announcements | Jupiter Green InvTst: New research - Vimarsana News

Investegate |Jupiter Green InvTst Announcements | Jupiter Green InvTst: New research

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional bod...

Investegate |VietNam Holding Ltd Announcements | VietNam Holding Ltd: Share Buyback and Cancellation - Vimarsana News

Investegate |VietNam Holding Ltd Announcements | VietNam Holding Ltd: Share Buyback and Cancellation

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional bod...

Investegate |Destiny Pharma PLC Announcements | Destiny Pharma PLC: Destiny Pharma Investor Presentation - Vimarsana News

Investegate |Destiny Pharma PLC Announcements | Destiny Pharma PLC: Destiny Pharma Investor Presentation

About Destiny Pharma Destiny Pharma is a clinical stage, innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening infections. Its pipeline has novel microbiome-based biotherapeutics and XF drug clinical assets including NTCD-M3, a Phase 3 ready treatment for the prevention of C. difficile infection (CDI) recurrence which is the leading cause of hospital acquired infection in the US and also XF-73 nasal gel, which is in a Phase 2b clinical trial targeting the prevention of post-surgical Staphylococcal hospital including MRSA...